where they create clothing that kills bacteria, conducts electricity, wards off malaria, captures harmful gas and weaves transistors into shirts and dresses. otton is one of the most fascinating and misunderstood materials,
Malaria kills more than 600,000 people annually in Africa. While insecticide-treated nets are common in African homes
"Some pathogens, such as malaria, typically trigger the creation of short-lived plasma cells. If we don't create long-lived plasma cells,
#Malaria's key to the liver uncovered Scientists uncover a port of liver entry for malaria parasites in a report published in The Journal of Experimental Medicine.
Malaria is caused by a parasite called Plasmodium falciparum, which is transmitted to humans via mosquito bite. Recent efforts to limit parasite transmission and increase treatment coverage has reduced the number of malaria-related deaths,
but the parasite still causes roughly 200 million new infections and half a million deaths worldwide each year.
CD68 may represent a potential new drug target in the fight against malaria a
#Study finds non-genetic cancer mechanism Cancer can be caused solely by protein imbalances within cells,
such as diagnosing and tracking Malaria and TB. It can also be applied to blood diseases, like sickle cell anemia,
for example, look at a Malaria infected patient, or TB infected patient and potentially decide on a drug choice based on some of the genetic testing copy number variations of certain genes that you would find in the sample taken from the patient. he technology also removes barriers to testing that cities
and our aging population. ext up the researchers plan to test their device in the field to detect the presence of malaria-related drug resistance.
Malaria, HIV and other illnesses. It could be useful identifying chemicals used in certain types of paint.
```Leishmaniasis is mainly spread by sand flies. Depending on the parasite species, symptoms of infection may include large skin lesions, fever, swelling of the spleen and liver,
Bolivia and Belgium examined data on 97 leishmaniasis patients. These were gathered through a project on drug resistance,
leishmaniasis is common in people who work in agriculture and forestry, said lead author Vanessa Adaui, Ph d,
treatment failure is a major obstacle to the control of infectious diseases like leishmaniasis, said Dujardin. t is of uppermost importance to understand the factors contributing to this failure to better tackle it.
But the failure rate was only 24 percent in patients with parasites that were free of the virus. The standard treatment for leishmaniasis differs based on the parasite species that causes the infection
The scientists are investigating how viral infection makes leishmaniasis more difficult to cure. According to Beverley, the parasites infected with the virus may be interacting with patientsimmune systems in a way that disrupts treatment.
#A paper microscope that costs only 50 cents can detect malaria from just a drop of blood
Practically, the Foldscope can help doctors correctly diagnose deadly diseases such as malaria, schistosomiasis, and African sleeping sickness.
With cheap, easy-to-use microscopes, any lab technician can learn to detect malaria, potentially revolutionizing healthcare in areas where these diseases run rampant.
such as a malaria-centric one, that make identifying diseases even easier. TEDTHE completed Foldscope fits any standard microscrope slide.
Anopheles gambiae, a major malaria vector, is isolated interbreeding with pockets of another malaria mosquito, A. coluzzii. Entomologists initially considered them as the
The World health organization World Malaria Report indicates that deaths from malaria worldwide have decreased by 47 percent since 2000.
Now there n urgent need to develop new and effective malaria vector control strategies, Lanzaro says.
#New Target Blocks Malaria Invasion and Transmission With close to 50%of the world population living in endemic areas and it being one of the leading causes of death in children under the age of 5,
malaria is a scourge that humans have endured since before they could walk fully upright. Moreover, the rate of resistance to current drug therapies is growing exponentially
The scientists found that a malaria protein called calcineurin is essential for parasite invasion into red blood cells."
particularly in light of the huge disease burden of malaria,"explained senior author Manoj Duraisingh, Ph d.,professor of Immunology and Infectious diseases at the T. H. Chan School of Public health."
"As drug resistance is a major problem for malaria control and eradication, it is critical that that we continue to develop new antimalarials that act against previously unexploited targets in the parasite to keep priming the drug pipeline."
implicating the protein as a potential target for blocking malaria transmission. Since there is much genetic conservation among parasites in the Apicomplexa phylum,
as it prevented cellular attachment in this parasite species as wellpening up the potential that calcineurin could target other parasitic diseases in addition to malaria."
If so, one might program those cells to collaboratively diagnose the flu or malaria: just add saliva to a packet of yeast
#World First Malaria Vaccine Approved and it Will be Not-for-Profit The world first malaria vaccine has been given approval by a European medical agency for future use in Sub-saharan africa, where more than a quarter million children under the age of five die every year from the disease.
European regulators examined phase III clinical trial results involving more than 16,000 young children conducted by research centers in eight African countries (Burkina faso, Gabon, Ghana, Kenya, Malawi, Mozambique, Nigeria
with all that money going back into further research for a malaria vaccine that could be even more effective.
along with current Malaria prevention techniques, like bed nets. 80%of the children involved in the clinical trials were protected also by insecticide treated bed nets.
malaria cases were reduced by almost half in children aged 5-17 months at the time of first vaccination and by 27%in infants aged 6-12 weeks.
At study end, over four years of follow-up in children RTS, S reduced malaria cases by 39,
In areas of the highest malaria burden, more than 6 000 clinical malaria cases were prevented over the study period for every 1, 000 children vaccinated
#Nest Thermostats Now Link Up to Products From LG Philips Whirlpool and Others Last June, Nest announced some big names in the first round of integration with its thermostat,
"The ability to detect even smaller amounts of chemical and biological molecules could be helpful with biosensors that are used to detect cancer, Malaria, HIV and other illnesses."
where they create clothing that kills bacteria, conducts electricity, wards off malaria, captures harmful gas and weaves transistors into shirts and dresses.
Malaria kills more than 600,000 people annually in Africa. While insecticide-treated nets are common in African homes
The researchers also say that single-administration delivery systems for the radical treatment of malaria
#Laser'tricorder'can diagnose malaria through the skin It's a weapon that fights malaria a laser scan can give an accurate diagnosis in seconds,
detecting malaria infections in only 20 seconds.""It's the first true noninvasive diagnostic, "says Dmitri Lapotko of Rice university in Houston, Texas,
whose team used the probe to correctly identify which person had malaria in a test of six individuals.
Malaria threatens half the world's population, killing 584,000 people in 2013. Existing tests for malaria are already quick,
taking only 15 to 20 minutes to give a diagnosis, but they could be simpler.
"The possibility of diagnosing a malaria infection with the device, without any blood-taking and with results available in seconds will provide a fantastic new tool for the control
and eventual elimination of malaria,"says Umberto D'Alessandro of the UK Medical Research Council Unit in Gambia."
if a patient has a dark skin a potentially huge pitfall given that children living in Africa account for the majority of malaria deaths.
In remote areas where dengue fever or malaria can take hold, the impact of drone technology and number of saved lives could be huge.
#Treating Cerebral Malaria: New Molecular Target Identified A drug already approved for treating other diseases may be useful as a treatment for cerebral malaria, according to researchers at Harvard T. H. Chan School of Public health.
They discovered a novel link between food intake during the early stages of infection and the outcome of the disease, identifying two molecular pathways that could serve as new targets for treatment."
but we were surprised at how rapidly a mild reduction in food intake could improve outcome in a mouse malaria model,
"However, the real importance of this work is the identification of unexpected molecular pathways underlying cerebral malaria that we can now target with existing drugs."
Cerebral malaria--a severe form of the disease--is the most serious consequence of infection by the parasite Plasmodium falciparum,
Currently there is a lack of safe treatment options for cerebral malaria, particularly for use in children,
but also in activating adaptive immune and inflammatory responses--is increased upon infection in a mouse model of cerebral malaria,
or nutritionally by reducing food intake during the first two days of infection, protected against cerebral malaria.
In their animal model, treating mice with the mtor inhibitor rapamycin protected them against the neurological complications of cerebral malaria.
trials in humans for cerebral malaria treatment with this drug may be possible, according to the researchers e
and where monocytes are programs in response to toxoplasmosis, an infection caused by a common parasite called Toxoplasma gondii.
#Protein discovery fuels redesign of mosquito-based malaria vaccine A promising type of vaccine designed to eradicate malaria by blocking parasite transmission could be a step closer,
and Dr Rhoel Dinglasan from the Malaria Research Institute at the Johns Hopkins Bloomberg School of Public health in Baltimore, USA, focused on a protein in the Anopheles mosquito midgut called Anapn1.
Malaria is transmitted to humans by the bite of a mosquito infected with the Plasmodium parasite.
Malaria transmission-blocking vaccines are designed to prevent the spread of malaria by interrupting parasite transmission.
Vaccinated individuals in malaria-endemic countries produce antibodies to Anapn1. During routine disease transmission, when these same immunised individuals become infected with malaria parasites,
The Anapn1 protein is a leading candidate for a mosquito-based malaria transmission-blocking vaccine that is being developed by Dr Dinglasan."
"This type of vaccine won't boost people's immunity to malaria, but instead it will provide a delayed benefit to the individual by protecting the entire community from parasite transmission,
Malaria is caused by a parasite that lives inside an infected mosquito and is transferred into the human through a bite.
The discovery could be the first step in developing a new drug to treat malaria. The scientists--funded by the Medical Research Council (MRC)
"This is a real breakthrough in our understanding of how malaria survives in the blood stream
and if it can be targeted by drugs we could see something that stops malaria in its tracks without causing toxic side-effects."
and also helps to avoid drug resistance which is a major problem in the control of malaria worldwide."
"According to the World health organization malaria currently infects more than 200 million people world wide and accounts for more than 500,000 deaths per year.
Most deaths occur among children living in Africa where a child dies every minute of malaria and the disease accounts for approximately 20%of all childhood deaths.
"Tackling malaria is a global challenge, with the parasite continually working to find ways to survive our drug treatments.
and the new findings suggest that parasite calcineurin should be a focus for the development of new antimalarial drugs. ur study has great biological and medical significance, particularly in light of the huge disease burden of malaria,
John Laporte Given Professor of Immunology and Infectious diseases. s drug resistance is a major problem for malaria control and eradication,
show the importance of calcineurin through different stages of the malaria life-cycle, implicating the protein as a potential target for blocking malaria transmission.
In addition to opening the door to potential new malaria treatments, these studies suggest that calcineurin could be targeted to treat other parasitic diseases.
Researchers at Boston College working in collaboration with the Harvard Chan group showed that calcineurin is also important for cellular attachment by a related parasite that causes toxoplasmosis. ur study shows that the ability of malaria parasites to engage red blood cells is driven by an ancient mechanism
for cellular attachment said lead author Aditya Paul, a postdoctoral researcher at the Harvard Chan School. n addition to a possible drug target,
where they create clothing that kills bacteria, conducts electricity, wards off malaria, captures harmful gas and weaves transistors into shirts and dresses. otton is one of the most fascinating and misunderstood materials,
Malaria kills more than 600,000 people annually in Africa. While insecticide-treated nets are common in African homes
The researchers also say that single-administration delivery systems for the radical treatment of malaria
who plans to use the handheld device to study mosquitoes that transmit malaria and other diseases in the Amazon."
Aedes aegypti isn't known for carrying malaria but it is responsible for spreading other deadly diseases like yellow fever, dengue fever,
#World's first malaria vaccine gets green light from European regulatory agency The world's first malaria vaccine has cleared its last major hurdle on its way to being approved for real-world use.
It's not the only vaccine developed to fight malaria; an experimental malaria vaccine called Pfspz was found to be much more effective at preventing malaria infection.
Yet Mosquirix is the first to make it this far along in the approval process. Mosquirix helps to prevent infection from the Plasmodium falciparum, one of the deadlier malaria parasites.
and children's chances of getting severe malaria or dying did not change at all. Some scientists are concerned that the potential costs associated with such a complex
Still, Africa is need in desperate for a malaria vaccine, even if it's only partially effective.
Malaria infection spread through the blood by mosquito bites kills upwards of 500 000 people each year.
"This vaccine could mean children will have only two bouts of malaria a year instead of five,"Dr. Martin De Smet,
a malaria expert at Doctors Without Borders, told the Huffington Post. THE WHO must decide if that is justification enough to recommend Mosquirix to the public h
< Back - Next >
Overtext Web Module V3.0 Alpha
Copyright Semantic-Knowledge, 1994-2011